Taperin activators represent a broad class of chemicals that indirectly enhance the functional activity of taperin by influencing specific biochemical pathways that it is directly involved in. This group of chemicals includes adenylyl cyclase activators such as Forskolin, selective phosphodiesterase-4 and -3 inhibitors like Rolipram and Milrinone, and a non-selective phosphodiesterase inhibitor, IBMX. These compounds enhance the intracellular levels of cAMP, a second messenger that activates Protein Kinase A (PKA). PKA is known to phosphorylate and activate several proteins, and it is plausible that it could phosphorylate and activate taperin, as per the logical analysis.
Moreover, the list includes an array of receptor agonists such as Salbutamol, Brimonidine, Clonidine, and Pilocarpine, which are beta-2 and alpha-2 adrenergic receptor agonists, and a muscarinic acetylcholine receptor agonist, respectively. These receptor agonists, upon binding, can increase cAMP levels, leading to PKA activation and potential taperin activation. Donepezil, an acetylcholinesterase inhibitor, increases acetylcholine levels, which can activate muscarinic acetylcholine receptors, subsequently increasing cAMP levels and potentially activating taperin. The list is rounded off by additional selective PDE3 inhibitors, Cilostazol and Sildenafil, further demonstrating the role of cAMP and PKA in potential taperin activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a direct activator of adenylyl cyclase, which increases intracellular cAMP levels. This can activate Protein Kinase A (PKA), which could phosphorylate taperin, leading to its activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase-4 inhibitor which increases cAMP levels, leading to PKA activation. This could indirectly activate taperin through phosphorylation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor which prevents the breakdown of cAMP, leading to PKA activation. This could indirectly activate taperin through phosphorylation. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H89 is a potent PKA inhibitor. However, in the presence of high levels of cAMP, it can fail to inhibit PKA, leading to the potential activation of taperin. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol is a beta-2 adrenergic receptor agonist which can increase cAMP levels and PKA activation, potentially leading to taperin activation through phosphorylation. | ||||||
Clonidine | 4205-90-7 | sc-501519 | 100 mg | $240.00 | 1 | |
Clonidine is an alpha-2 adrenergic receptor agonist similar to Brimonidine, and it can also increase cAMP levels, leading to PKA activation and potential taperin activation. | ||||||
(+)-Pilocarpine hydrochloride | 54-71-7 | sc-203196 sc-203196A sc-203196B | 1 g 100 g 10 g | $62.00 $3641.00 $520.00 | 3 | |
Pilocarpine is a muscarinic acetylcholine receptor agonist. Activation of these receptors can increase cAMP levels, leading to PKA activation and potential taperin activation. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Donepezil increases acetylcholine levels, which can activate muscarinic acetylcholine receptors, increase cAMP levels, activate PKA, and potentially activate taperin. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a selective phosphodiesterase-3 inhibitor. By inhibiting PDE3, it increases cAMP levels, activates PKA, and could potentially activate taperin. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol is another selective PDE3 inhibitor. By increasing cAMP levels and activating PKA, it could potentially activate taperin. | ||||||